Aducanumab Injection [Aduhelm]
RxNorm 2557227

Concept Hierarchy & Relationship Mapping

RxNorm Concept Unique Identifier (RxCUI) 2557227 represents a standardized clinical drug concept used for cross-system interoperability. This concept aggregates multiple Atom IDs (AUIs), which are specific naming variations and synonyms used across pharmaceutical databases to ensure accurate medication mapping for: aducanumab Injection [Aduhelm].

The following semantic concepts and normalized strings are associated with this clinical entity:

SBDF
Aducanumab Injection [Aduhelm]
AUI:12646258
View

This clinical crossover tool is designed for healthcare professionals, pharmacists, and data analysts to safely compare substitute products and manage medication interoperability.

SBDFPrescribable

Semantic Branded Drug Form (SBDF):
Aducanumab Injection [Aduhelm]
(Atom ID: 12646258)

Clinical Status & Identity

Prescribable Status
YES (Active)
Part of the RxNorm Current Prescribable Content subset including all drugs available for prescription in the USA.
Concept Description
aducanumab Injection [Aduhelm]
Official description of the drug concept as defined in the source vocabulary.
Suppress Flag
N
N: Not suppressible | O: Obsolete | Y: Suppressed by editor | E: Unquantified non-prescribable drug.

Interoperability & Coding

Concept ID (RxCUI)
2557227
RxNorm Unique Identifier for the standardized concept.
Atom ID (RXAUI)
12646258
Unique identifier for this specific name variation (Atom).
Term Type (TTY)
SBDF
Semantic Branded Drug Form (Ingredient + Dose Form + Brand Name)
Source Code
2557227
The "Most useful" identifier asserted by the original source vocabulary.

Source & Registry Data

Source Name
RxNorm Vocabulary (RXNORM)
The official name and abbreviation for the vocabulary source.
Source Version
20AA_260601F
The specific version of the vocabulary provided by the source.
Update Date
June 01, 2026
The date when this RxNorm data was last updated by the NLM.
License Contact
RxNorm Customer Service, , U.S. National Library of Medicine, 8600 Rockville Pike, , Bethesda, MD, United States, 20894, (888) FIND-NLM, , https://support.nlm.nih.gov/support/create-case/, https://www.nlm.nih.gov/research/umls/rxnorm/
Source licensing contact information.

Patient Education

Aducanumab-avwa Injection


Aducanumab-avwa injection is used to reduce amyloid beta plaque, a protein found in the brain of people with Alzheimer's disease (a brain disease that slowly destroys the memory and ability to think, learn, communicate and handle daily activities). It is used to treat people with mild cognitive impairment (MCI) or mild dementia. Aducanumab-avwa injection is in a class of medications called monoclonal antibodies. It works by blocking the formation of amyloid beta in the brain.
[Learn More]


* Please review the disclaimer below.